Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Receivables: 2020-2025

Historic Change in Receivables for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to -$2.5 million.

  • Beauty Health's Change in Receivables rose 12.67% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year increase of 48.77%. This contributed to the annual value of -$20.8 million for FY2024, which is 25.93% down from last year.
  • As of Q3 2025, Beauty Health's Change in Receivables stood at -$2.5 million, which was down 245.67% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Beauty Health's Change in Receivables peaked at $20.3 million during Q2 2022, and registered a low of -$10.5 million during Q4 2023.
  • For the 3-year period, Beauty Health's Change in Receivables averaged around -$3.8 million, with its median value being -$4.6 million (2024).
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 3,776.55% in 2021, then crashed by 198.79% in 2023.
  • Quarterly analysis of 5 years shows Beauty Health's Change in Receivables stood at $13.7 million in 2021, then slumped by 162.70% to -$8.6 million in 2022, then dropped by 22.17% to -$10.5 million in 2023, then rose by 29.08% to -$7.5 million in 2024, then rose by 12.67% to -$2.5 million in 2025.
  • Its Change in Receivables was -$2.5 million in Q3 2025, compared to $1.7 million in Q2 2025 and -$4.0 million in Q1 2025.